AGENDA
AGENDA
Fairmont Hotel Lake Louise
FRIDAY, MARCH 22, 2024
ALLIED HEALTH Professionals Program – Mt. Temple Ballroom
| 1100 – 1200h | Registration and Lunch – Heritage Hall |
| 1200 – 1540h | ALLIED HEALTH Professionals Program |
| 1200 – 1205h | Opening Remarks – Ms. Nanette Cox-Kennett and Ms. Nikki Blosser |
| 1205 – 1250h | Decoding Clinical Research: A Guided Walkthrough of a Recent CLL Trial – Ms. Cindy Railton, NP |
| 1250 – 1335h | Take Home Chemotherapy – Bortezomib for Myeloma – Dr. Jason Tay |
| 1335 – 1420h | Chronicity Concerns in Lymphoproliferative Disorders – Dr. Edith Pituskin, NP |
| 1420 – 1505h | Transitioning to Palliative Care – A Guide to Difficult Conversations – Dr. Charlie Chen |
| 1505 – 1535h | One Patient’s Personal Review of Commendations and Areas for Improvement in Cancer Care – Ms. Sharon Mallon |
| 1535 – 1540h | Closing Remarks/ Evaluation Review – Ms. Nanette Cox-Kennett |
| 1600 – 1700h | Registration and Welcome Reception – Heritage Hall |
| 1700 – 1710h | Opening Remarks – Dr. Wendy Lam, Dr. Laurie Sehn – Mt. Temple Ballroom |
MYELOMA SESSION – Mt. Temple Ballroom
Chairs: Dr. Irwin Sandhu and Dr. Darrell White
| 1710 – 1730h | Controversies in Transplant Eligible Myeloma Patients – Dr. Saad Usmani |
| 1730 – 1750h | Considerations for Next Therapies After AntiCD38 Monoclonal Antibodies – Dr. Alissa Visram |
| 1750 – 1820h | Best Practice Integrating CART and Bispecifics Into Our Clinics – Dr. Saad Usmani |
| 1820 – 1840h | Aligning Real World Data with Clinical Trials in Myeloma – Dr. Alissa Visram |
| 1840 – 1925h | Panel – Challenging Myeloma Cases Chairs: Dr. Irwin Sandhu, Dr. Darrell White Panel: Dr. Saad Usmani, Dr. Alissa Visram |
| 1930h – | Dinner |
SATURDAY, MARCH 23, 2024
CLL SESSION – Mt. Temple Ballroom
Chair Dr. Julie Stakiw
| 0630 – 0700h | Breakfast |
| 0700 – 0705h | Welcome and Introductions – |
| 0705 – 0725h | Who/When to Start CLL Treatment in the Era of Highly Effective Therapy? – Dr. Deborah Stephens |
| 0725 – 0750h | Treatment for Newly Diagnosed CLL – Dr. Othman Al-Sawaf |
| 0750 – 0820h | Treatment for Relapsed/Refractory CLL – Dr. Alina Gerrie |
| 0820 – 0840h | Overcoming Resistance in CLL – Dr. Othman Al-Sawaf |
| 0840 – 0900h | What’s new in Richter’s Syndrome? – Dr. Deborah Stephens |
| 0900 – 1000h | Panel – Challenging CLL Cases Chair: Dr. Julie Stakiw Panel: Dr. Othman Al-Sawaf, Dr. Alina Gerrie, Dr. Deborah Stephens |
| 1300 – 1645h | Young Investigators’ Poster and Oral Presentations |
LYMPHOMA SESSION – Mt. Temple Ballroom
Chair: Dr. Wendy Lam
| 1700 – | Welcome and Introductions – |
| 1700 – 1705h | Young Investigators Presentation of Best Poster – Dr. Pam Skrabek |
| 1705 – 1735h | Management of Hodgkin Lymphoma in the Era of Novel Therapy – Dr. Michael Crump |
| 1735 – 1755h | Promise of Circulating Tumour DNA in Lymphoma – Dr. David Scott |
| 1755 – 1820h | Post CAR T-Cell Therapy Care – Dr. Kevin Hay |
| 1820 – 1845h | Best of ASH – Dr. Nathalie Johnson |
| 1845 – 1920h | Panel – Challenging Lymphoma Cases Chair: Dr. Wendy Lam Panel: Dr. Michael Crump, Dr. David Scott, Dr. Kevin Hay, Dr. Nathalie Johnson |
| 19:30 – | Dinner |
SUNDAY, MARCH 24, 2024
LYMPHOMA SESSION – Mt. Temple Ballroom
Chair: Dr. Pam Skrabek
| 0630 – 0700h | Breakfast |
| 0700 – 0705h | Welcome and Introductions – |
| 0705 – 0735h | Molecular Subtyping of DLBCL, What is Clinically Relevant and What is Dark Zone Lymphoma – Dr. David Scott |
| 0735 – 0805h | What is the Worldwide Standard for Untreated LBCL? – Dr. Michael Dickinson |
| 0805 – 0835h | The Evolving Algorithm for R/R LBCL – Dr. Laurie Sehn |
| 0835 – 0905h | Use of Bispecifics in Lymphoma – Dr. Michael Dickinson |
| 0905 – 0955h | Panel – Challenging Lymphoma Cases Chair: Dr. Pam Skrabek Panel: Dr. Michael Dickinson, Dr. Kevin Hay, Dr. David Scott, Dr. Laurie Sehn |
| 0955 – 1000h | Closing Remarks – Dr. Laurie Sehn, Dr. Wendy Lam |